Cardiology researchers at the Intermountain Medical Center Heart Institute have found that 75 percent of patients taking two common blood-thinning drugs may be receiving the wrong dosage levels. The Utah researchers presented their findings today (TUES) at an American Heart Association conference in Los Angeles.
